PRESS RELEASE published on 02/22/2024 at 15:00, 8 months 27 days ago Sustained Acoustic Medicine Helps Veteran Triathlete Maintain Peak Performance and Rapid Recovery Claudia McCoy, top-tier triathlete and USAT Certified Triathlon Coach, endorses the sam® wearable ultrasound for injury recovery and training. Developed by ZetrOZ Systems, the sustained acoustic medicine aids in faster recovery without surgery or pain medication ZetrOZ Systems Sustained Acoustic Medicine Wearable Ultrasound Claudia McCoy Triathlete
BRIEF published on 02/22/2024 at 15:00, 8 months 27 days ago Claudia McCoy, champion triathlete, returns to the top thanks to ZetrOZ Systems' sam® technology ZetrOZ Systems Claudia McCoy Triathlon Sam® Technology Sports Recovery
BRIEF published on 02/22/2024 at 15:00, 8 months 27 days ago Claudia McCoy, championne triathlète, revient au sommet grâce à la technologie sam® de ZetrOZ Systems ZetrOZ Systems Claudia McCoy Triathlon Technologie Sam® Récupération Sportive
PRESS RELEASE published on 02/13/2024 at 18:45, 9 months 7 days ago ZetrOZ Systems to Showcase Sustained Acoustic Medicine at the American Academy of Orthopedic Surgeons Annual Meeting ZetrOZ Systems to display sam® wearable ultrasound unit at AAOS 2024 annual meeting, showcasing FDA-cleared treatment for soft tissue healing and injury recovery. Technology complements orthopedic procedures ZetrOZ Systems Soft Tissue Healing Orthopedic Surgery Sam® Wearable Ultrasound Unit AAOS 2024 Annual Meeting
PRESS RELEASE published on 01/24/2024 at 15:00, 9 months 27 days ago ZetrOZ Systems to Demonstrate sam Wearable Ultrasound Unit at Las Vegas Conference ZetrOZ Systems, the inventor of sustained acoustic medicine, will be demonstrating its sam® X1 wearable ultrasound unit for healthcare providers at The Las Vegas Regenerative Medicine and MSK Ultrasound Course. This event aims to train orthopedic surgeons, sports medicine physicians, physical therapists, and other health practitioners in the latest musculoskeletal ultrasound and regenerative medicine technologies. Dr. Don Buford, a top orthopedic surgeon, praises ZetrOZ Systems' technology for its ability to promote soft tissue healing, and the conference will feature a session focusing on the evidence-based best practices in orthopedics, including therapeutic ultrasound use. ZetrOZ Systems' long-duration ultrasound treatment technology has been documented in numerous peer-reviewed publications and clinical studies, aligning well with the conference's goals. The company's founder and CEO, George K. Lewis, aims to educate a wider clinical audience on the value of sustained acoustic medicine and its application in treating soft tissue injuries. Sustained Acoustic Medicine Wearable Ultrasound Regenerative Medicine Orthopedic Surgeons Musculoskeletal Ultrasound
PRESS RELEASE published on 01/22/2024 at 16:15, 9 months 29 days ago ZetrOZ Systems to Showcase sam(R) Ultrasound Treatment Technology at the 2024 Big Sky Sports Medicine Conference ZetrOZ Systems, the makers of the sam® wearable ultrasound unit, will be presenting its sustained acoustic medicine technology at the 26th annual Big Sky Sports Medicine Conference. The presentations will focus on the effectiveness of sustained acoustic medicine in soft tissue healing, showcasing the sam X1 and sam 2.0 devices, both cleared by the FDA for expanded indications to treat soft tissue injuries and knee osteoarthritis. This ground-breaking treatment has been clinically validated in over 40 studies and is designed to accelerate soft tissue healing and relieve pain without invasive procedures. Find out more at www.samrecover.com. ZetrOZ Systems Sustained Acoustic Medicine Soft Tissue Healing Sam Wearable Ultrasound Unit Big Sky Sports Medicine Conference
PRESS RELEASE published on 01/16/2024 at 17:00, 10 months 4 days ago The Orthobiologic Institute and ZetrOZ Systems Launch 2024 Clinical Education Program on Non-Opioid and Non-Surgical Soft-Tissue Regenerative Techniques for Clinicians Clinical education director Dr. Rajiv Mallipudi will lead an exclusive webinar series with The Orthobiologic Institute to train clinicians on sustained acoustic medicine and its effectiveness in soft tissue healing using the sam® ultrasound unit. The program will explore the science behind sam®, treatment protocols, and its applications in sports-related injuries, offering standardized guidelines for effective use. This collaboration aims to advance the understanding of regenerative ultrasound technology and its impact on healthcare standards. Clinical Education Sustained Acoustic Medicine Sam® Ultrasound Soft Tissue Healing Orthobiologics
PRESS RELEASE published on 01/09/2024 at 18:45, 10 months 11 days ago ZetrOZ Systems’ sam 2.0 Wearable Ultrasound Unit Receives New FDA Clearance for Expanded Medical Indications ZetrOZ Systems' sam® 2.0 long-duration wearable ultrasound unit has received clearance from the U.S. Food and Drug Administration for expanded indications to treat soft tissue injuries and knee osteoarthritis, making the sustained acoustic medicine device more accessible to a wider range of medical conditions. The FDA's decision signifies the device's safety and effectiveness, paving the way for increased utilization in both professional sports and general population healthcare. The company's founder and CEO, George K. Lewis, highlights the significance of the FDA clearance, emphasizing the numerous studies demonstrating the technology's efficacy in treating injuries without the need for oral medication, corticosteroids, or surgery. ZetrOZ Systems Sam® 2.0 Wearable Ultrasound Unit Sustained Acoustic Medicine Technology FDA Clearance
PRESS RELEASE published on 12/15/2023 at 21:00, 11 months 5 days ago ZetrOZ Systems Supports 2023 Major League Soccer Medical Symposium and Highlights Sustained Acoustic Medicine Innovation
PRESS RELEASE published on 12/06/2023 at 20:30, 11 months 14 days ago ZetrOZ Systems Sponsors Event for Athletic Trainers at Major League Baseball Winter Meetings ZetrOZ Systems to present on sustained acoustic medicine technology's effectiveness in promoting soft tissue healing at the Professional Baseball Athletic Trainers Society (PBATS) meeting during Major League Baseball's Winter Meetings 2023 ZetrOZ Systems Wearable Ultrasound Unit Sustained Acoustic Medicine Soft Tissue Healing PBATS Meeting
Published on 11/21/2024 at 14:30, 24 minutes ago Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis
Published on 11/21/2024 at 14:30, 24 minutes ago Sarama Announces Equity Placement of Up to A$2M and Issue of Equity for Debt
Published on 11/21/2024 at 14:15, 39 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 54 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 54 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:16, 37 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 39 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 13:41, 1 hour 13 minutes ago Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Published on 11/21/2024 at 06:58, 7 hours 56 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 7 hours 56 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 7 hours 56 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 18 hours 46 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 19 hours 34 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting